Valpoic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus
- 30 June 1994
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 91 (2-3), 111-121
- https://doi.org/10.1016/0009-2797(94)90031-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Glutathione deficiency and human immunodeficiency virus infectionThe Lancet, 1992
- Inhibition of human red blood cell glutathione reductase by valproic acidBiochemical Pharmacology, 1992
- N-Acetylcysteine: A New Approach to Anti-HIV TherapyAIDS Research and Human Retroviruses, 1992
- The Effect of Cytokines and Pharmacologic Agents on Chronic HIV InfectionAIDS Research and Human Retroviruses, 1992
- N-Acetylcysteine Inhibits Latent HIV Expression in Chronically Infected CellsAIDS Research and Human Retroviruses, 1991
- Inhibition of HIV-1 replication and NF-x B activity by cysteine and cysteine derivativesAIDS, 1991
- Glutathione deficiency produced by inhibition of its synthesis, and its reversal; Applications in research and therapyPharmacology & Therapeutics, 1991
- Valproate-Associated Hepatotoxicity and its Biochemical MechanismsMedical Toxicology, 1988
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Mechanism of anticonvulsant action of valproateProgress in Neurobiology, 1982